Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

OBJECTIVE: Obtain a more precise estimate of the efficacy of delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) in relapsing multiple sclerosis (MS) and examine the consistency of DMF's effects across patient subgroups stratified by baseline demographic and disease char...

Descripción completa

Detalles Bibliográficos
Autores principales: Viglietta, Vissia, Miller, David, Bar-Or, Amit, Phillips, J Theodore, Arnold, Douglas L, Selmaj, Krzysztof, Kita, Mariko, Hutchinson, Michael, Yang, Minhua, Zhang, Ray, Dawson, Katherine T, Sheikh, Sarah I, Fox, Robert J, Gold, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338952/
https://www.ncbi.nlm.nih.gov/pubmed/25750916
http://dx.doi.org/10.1002/acn3.148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338952/
https://www.ncbi.nlm.nih.gov/pubmed/25750916
http://dx.doi.org/10.1002/acn3.148

Ejemplares similares